Bloodstream infections among patients receiving therapeutic plasma exchanges in the intensive care unit: a 10 year multicentric study.
Bloodstream infections
Critical care
Health-care acquired infections
Intensive care unit
Intra-vascular catheter infection
Therapeutic plasma exchange
Journal
Annals of intensive care
ISSN: 2110-5820
Titre abrégé: Ann Intensive Care
Pays: Germany
ID NLM: 101562873
Informations de publication
Date de publication:
29 Jul 2024
29 Jul 2024
Historique:
received:
05
02
2024
accepted:
29
06
2024
medline:
29
7
2024
pubmed:
29
7
2024
entrez:
29
7
2024
Statut:
epublish
Résumé
Therapeutic plasma exchanges (TPE), which affect the humoral response, are often performed in combination with immunosuppressive drugs. For this reason, TPE may be associated with an increased susceptibility to infections. We aimed to describe blood stream infection (BSI) incidence in ICU patients treated with TPE and to identify associated risk factors. We retrospectively included patients that had received at least one session of TPE in the ICU of one of the 4 participating centers (all in Paris, France) between January 1st 2010 and December 31th 2019. Patients presenting with a BSI during ICU stay were compared to patients without such an infection. Risk factors for BSI were identified by a multivariate logistic regression model. Over 10 years in the 4 ICUs, 387 patients were included, with a median of 5 [2-7] TPE sessions per patient. Most frequent indications for TPE were thrombotic microangiopathy (47%), central nervous system inflammatory disorders (11%), hyperviscosity syndrome (11%) and ANCA associated vasculitis (8.5%). Thirty-one patients (8%) presented with a BSI during their ICU stay, a median of 7 [3-11] days after start of TPE. In a multivariate logistic regression model, diabetes (OR 3.32 [1.21-8.32]) and total number of TPE sessions (OR 1.14 [1.08-1.20]) were independent risk factors for BSI. There was no difference between TPE catheter infection related BSI (n = 11 (35%)) and other sources of BSI (n = 20 (65%)) regarding catheter insertion site (p = 0.458) or rate of TPE catheter related deep vein thrombosis (p = 0.601). ICU course was severe in patients presenting with BSI when compared to patients without BSI, with higher need for mechanical ventilation (45% vs 18%, p = 0.001), renal replacement therapy (42% vs 20%, p = 0.011), vasopressors (32% vs 12%, p = 0.004) and a higher mortality (19% vs 5%, p = 0.010). Blood stream infections are frequent in patients receiving TPE in the ICU, and are associated with a severe ICU course. Vigilant monitoring is crucial particularly for patients receiving a high number of TPE sessions.
Sections du résumé
BACKGROUND
BACKGROUND
Therapeutic plasma exchanges (TPE), which affect the humoral response, are often performed in combination with immunosuppressive drugs. For this reason, TPE may be associated with an increased susceptibility to infections. We aimed to describe blood stream infection (BSI) incidence in ICU patients treated with TPE and to identify associated risk factors.
METHODS
METHODS
We retrospectively included patients that had received at least one session of TPE in the ICU of one of the 4 participating centers (all in Paris, France) between January 1st 2010 and December 31th 2019. Patients presenting with a BSI during ICU stay were compared to patients without such an infection. Risk factors for BSI were identified by a multivariate logistic regression model.
RESULTS
RESULTS
Over 10 years in the 4 ICUs, 387 patients were included, with a median of 5 [2-7] TPE sessions per patient. Most frequent indications for TPE were thrombotic microangiopathy (47%), central nervous system inflammatory disorders (11%), hyperviscosity syndrome (11%) and ANCA associated vasculitis (8.5%). Thirty-one patients (8%) presented with a BSI during their ICU stay, a median of 7 [3-11] days after start of TPE. In a multivariate logistic regression model, diabetes (OR 3.32 [1.21-8.32]) and total number of TPE sessions (OR 1.14 [1.08-1.20]) were independent risk factors for BSI. There was no difference between TPE catheter infection related BSI (n = 11 (35%)) and other sources of BSI (n = 20 (65%)) regarding catheter insertion site (p = 0.458) or rate of TPE catheter related deep vein thrombosis (p = 0.601). ICU course was severe in patients presenting with BSI when compared to patients without BSI, with higher need for mechanical ventilation (45% vs 18%, p = 0.001), renal replacement therapy (42% vs 20%, p = 0.011), vasopressors (32% vs 12%, p = 0.004) and a higher mortality (19% vs 5%, p = 0.010).
CONCLUSION
CONCLUSIONS
Blood stream infections are frequent in patients receiving TPE in the ICU, and are associated with a severe ICU course. Vigilant monitoring is crucial particularly for patients receiving a high number of TPE sessions.
Identifiants
pubmed: 39073720
doi: 10.1186/s13613-024-01346-7
pii: 10.1186/s13613-024-01346-7
doi:
Types de publication
Journal Article
Langues
eng
Pagination
117Informations de copyright
© 2024. The Author(s).
Références
Padmanabhan A, Connelly-Smith L, Aqui N, et al. Guidelines on the use of therapeutic apheresis in clinical practice—evidence‐based approach from the writing committee of the american society for apheresis: the eighth special issue. J Clin Apheresis. 2019;34:171–354.
doi: 10.1002/jca.21705
pubmed: 31180581
Bauer PR, Ostermann M, Russell L, et al. Plasma exchange in the intensive care unit: a narrative review. Intensive Care Med. 2022;48:1382–96.
doi: 10.1007/s00134-022-06793-z
pubmed: 35960275
pmcid: 9372988
Guptill JT, Juel VC, Massey JM, et al. Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis. Autoimmunity. 2016;49:472–9.
doi: 10.1080/08916934.2016.1214823
pubmed: 27684107
pmcid: 5440840
Corvetta A, Marchegiani G, Salvi A, et al. Immune complexes and complement profile in essential mixed cryoglobulinemia before and after plasma exchange. Int J Artif Organs. 1983;6(Suppl 1):65–8.
pubmed: 6642740
Timsit J-F, Ruppé E, Barbier F, et al. Bloodstream infections in critically ill patients: an expert statement. Intensive Care Med. 2020;46:266–84.
doi: 10.1007/s00134-020-05950-6
pubmed: 32047941
pmcid: 7223992
Walsh M, Merkel PA, Peh C-A, et al. Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis. N Engl J Med. 2020;382:622–31.
doi: 10.1056/NEJMoa1803537
pubmed: 32053298
pmcid: 7325726
Wing EJ, Bruns FJ, Fraley DS, et al. Infectious complications with plasmapheresis in rapidly progressive glomerulonephritis. JAMA. 1980;244:2423–6.
doi: 10.1001/jama.1980.03310210025020
pubmed: 7431570
François M, Daubin D, Menouche D, et al. Adverse events and infectious complications in the critically ill treated by plasma exchange: a five-year multicenter cohort study. Critic Care Explor. 2023;5: e0988.
doi: 10.1097/CCE.0000000000000988
Timsit J-F, Rupp M, Bouza E, et al. A state of the art review on optimal practices to prevent, recognize, and manage complications associated with intravascular devices in the critically ill. Intensive Care Med. 2018;44:742–59.
doi: 10.1007/s00134-018-5212-y
pubmed: 29754308
Gouel-Cheron A, Swihart BJ, Warner S, et al. Epidemiology of ICU-onset bloodstream infection: prevalence, pathogens, and risk factors among 150,948 ICU patients at 85 U.S. Hospitals. Crit Care Med. 2022;50:1725–36.
doi: 10.1097/CCM.0000000000005662
pubmed: 36190259
pmcid: 10829879
Tabah A, Buetti N, Staiquly Q, et al. Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study. Intensive Care Med. 2023;49:178–90.
doi: 10.1007/s00134-022-06944-2
pubmed: 36764959
pmcid: 9916499
Jung SI, Kim YE, Yun NR, et al. Effects of steroid therapy in patients with severe fever with thrombocytopenia syndrome: a multicenter clinical cohort study. PLoS Negl Trop Dis. 2021;15: e0009128.
doi: 10.1371/journal.pntd.0009128
pubmed: 33606699
pmcid: 7928499
Kollef MH, Torres A, Shorr AF, et al. Nosocomial Infection. Crit Care Med. 2021;49:169–87.
doi: 10.1097/CCM.0000000000004783
pubmed: 33438970
Basic-Jukic N, Kes P, Glavas-Boras S, et al. Complications of therapeutic plasma exchange: experience with 4857 treatments. Ther Apher Dial. 2005;9:391–5.
doi: 10.1111/j.1744-9987.2005.00319.x
pubmed: 16202013